- Bacterial skin infections:
- Cream/oint: Apply thin layer TDS
- Powder: Apply 2-4 times per day
- Ointment: 2,500 IU + 5,000 IU
- Powder: 0.5% w/w +250 IU/g
- None remarkable
Bacitracin: Cyclic polypeptide antibiotic. It inhibits peptidoglycan synthesis during the second step of bacterial cell wall synthesis by interfering with the activity of phosphorylase and is bactericidal.
Neomycin: Aminoglycoside antibiotic. It works by inhibiting bacterial protein synthesis leading to its bactericidal effect on gram-negative bacteria.
- Hypersensitivity reaction
- Possibility of ototoxicity and nephrotoxicity if used in large quantities or on large areas for prolonged use.
- Hypersensitivity to class/components
- Pre-existing nerve deafness
- Neonates and infants <2 years
- None restricted
Drug Status
| Availability | Prescription only |
| Pregnancy | Weigh risk vs benefit otherwise contraindicated |
| Breastfeeding | Weigh risk vs benefit |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Baneocin | 2,500 IU/5,000 IU | Ointment | 20g | Sandoz GMBH | Novartis Kenya |
| Nebanol | 0.5% w/w + 250 IU/g | Powder | 5g, 10g | Square Pharma | Ace Pharma |